Literature DB >> 18217946

Dependence of surface monoclonal antibody binding on dynamic changes in FcgammaRIIb expression.

Jennifer A Walker1, Kenneth G C Smith.   

Abstract

Receptors for the Fc region of immunoglobulin G (FcgammaRs) are expressed on a broad range of haematopoietic cell types and are responsible for regulating antibody production and linking the humoral and effector responses. In response to a number of stimuli, such as cytokine signals or inflammation, FcgammaR expression at the cell surface is dynamically regulated. On B cells, we observed what appeared to be a correlation between CD22 expression and FcgammaRIIb expression when the latter was varied in a number of models. Further investigation revealed that this was specific to a particular anti-CD22 monoclonal antibody, which appeared to require stabilization by interaction with FcgammaRIIb for optimal binding to CD22. Since alterations in the regulation of FcgammaR expression are important in controlling immune responses and have been associated with a number of immune-mediated disease states, we suggest that it might be prudent to confirm the expression of cell surface markers by two independent methods. Furthermore, because the efficacy of therapeutic antibodies may depend upon their interaction with FcgammaRs, our results are relevant to their design and assessment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18217946      PMCID: PMC2440835          DOI: 10.1111/j.1365-2567.2007.02791.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  Properties of a second epitope of the murine Fc receptor for aggregated IgG.

Authors:  E Puré; M D Witmer; J B Lum; I Mellman; J C Unkeless
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

Review 2.  Interaction sites on human IgG-Fc for FcgammaR: current models.

Authors:  Roy Jefferis; John Lund
Journal:  Immunol Lett       Date:  2002-06-03       Impact factor: 3.685

3.  Optimal conditions for the preparation of Fab and F(ab')2 fragments from monoclonal IgG of different rat IgG subclasses.

Authors:  J Rousseaux; R Rousseaux-Prévost; H Bazin
Journal:  J Immunol Methods       Date:  1983-11-11       Impact factor: 2.303

4.  Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma.

Authors:  Wen-Kai Weng; Ronald Levy
Journal:  J Clin Oncol       Date:  2003-09-15       Impact factor: 44.544

5.  Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact.

Authors:  Brian E Collins; Ola Blixt; Alexis R DeSieno; Nicolai Bovin; Jamey D Marth; James C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

Review 6.  Anti-lymphocyte antibodies in systemic lupus erythematosus.

Authors:  J B Winfield
Journal:  Clin Rheum Dis       Date:  1985-12

7.  Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.

Authors:  Sébastien Dall'Ozzo; Sophie Tartas; Gilles Paintaud; Guillaume Cartron; Philippe Colombat; Pierre Bardos; Hervé Watier; Gilles Thibault
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

8.  Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones.

Authors:  B Jones; J P Tite; C A Janeway
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

9.  Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22.

Authors:  Brian E Collins; Ola Blixt; Nicolai V Bovin; Claus-Peter Danzer; Daniel Chui; Jamey D Marth; Lars Nitschke; James C Paulson
Journal:  Glycobiology       Date:  2002-09       Impact factor: 4.313

Review 10.  Inhibitory Fc gamma receptors: from gene to disease.

Authors:  Radu N Stefanescu; Mikhail Olferiev; Yi Liu; Luminita Pricop
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

View more
  3 in total

1.  Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl-2 expression.

Authors:  Christian Bogner; Tobias Dechow; Ingo Ringshausen; Michaela Wagner; Madlen Oelsner; Gloria Lutzny; Thomas Licht; Christian Peschel; Ira Pastan; Robert J Kreitman; Thomas Decker
Journal:  Br J Haematol       Date:  2009-10-11       Impact factor: 6.998

Review 2.  Pseudomonas Exotoxin-Based Immunotoxins: Over Three Decades of Efforts on Targeting Cancer Cells With the Toxin.

Authors:  Seyed Mehdi Havaei; Marc G Aucoin; Ali Jahanian-Najafabadi
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

Review 3.  CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults.

Authors:  Francesco Lanza; Enrico Maffini; Michela Rondoni; Evita Massari; Angelo Corso Faini; Fabio Malavasi
Journal:  Cancers (Basel)       Date:  2020-01-28       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.